首页> 外文期刊>Surgery for obesity and related diseases: official journal of the American Society for Bariatric Surgery >The EFFORT trial: Preoperative enoxaparin versus postoperative fondaparinux for thromboprophylaxis in bariatric surgical patients: a randomized double-blind pilot trial
【24h】

The EFFORT trial: Preoperative enoxaparin versus postoperative fondaparinux for thromboprophylaxis in bariatric surgical patients: a randomized double-blind pilot trial

机译:EFFORT试验:减肥手术患者的术前依诺肝素与术后磺达肝癸钠预防血栓预防:一项随机双盲先导试验

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Prophylaxis for venous thromboembolism is routinely performed for all patients undergoing bariatric surgery. However, there is disagreement regarding the optimal dosing and duration of anticoagulant therapy. Furthermore, there is little data regarding the incidence of asymptomatic deep venous thrombosis (DVT) in this population. Our objective was to conduct a pilot randomized double blind study to evaluate the pharmacodynamic parameters of 2 different anticoagulation medications (enoxaparin and fondaparinux) administered to patients undergoing bariatric surgery.
机译:背景:所有接受减肥手术的患者均常规进行静脉血栓栓塞的预防。但是,关于抗凝治疗的最佳剂量和持续时间存在分歧。此外,关于该人群无症状深静脉血栓形成(DVT)的发生率的数据很少。我们的目标是进行一项试点随机双盲研究,以评估对减肥手术患者使用的两种不同抗凝药物(依诺肝素和磺达肝癸钠)的药效学参数。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号